Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: BIOLEGEND, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-12 to 2022-11-29
Current total value of award: $100882.25
Description: BIOLEGEND ANTIBODIES 59 TYPES FOR THE CITE-SEQ PLATFORM